๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

SHRUM-ALPHA-FETOPROTEIN IN MALIGNANT HEPATOMA

โœ Scribed by Huguet, C.; Gallot, D.; Hirsch-Marie, H.; Caroli, J.

Book ID
123561061
Publisher
The Lancet
Year
1974
Tongue
English
Weight
153 KB
Volume
303
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immunoradioautographic study of alpha-fe
Immunoradioautographic study of alpha-fetoprotein in hepatoma cells
โœ T. Suganuma; M. Koura; H. Isaka; Y. Tsukada; F. Murata ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› Springer ๐ŸŒ English โš– 823 KB

Trypsin treatment, which is frequently used in the field of immunocytochemistry to faciliate conjugated antibody penetration through the cell membrane, was applied for the immunoradiographic demonstration of alpha-fetoprotein in ascites hepatoma cells using 125I-labeled anti rat alpha-fetoprotein an

Multimodality cisplatin treatment in non
Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma
โœ Barry Epstein; Peter K. Leichner; Stanley E. Order; David Ettinger ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 520 KB

Twenty-eight patients with alpha-fetoprotein-positive (AFP+) nonresectable hepatoma have been enrolled in a new multimodality Phase I, II program. Induction therapy consisted of 50 mg/m2 intravenous cisplatin followed by 2100 cGy irradiation to the tumor volume in seven fractions over 10 days. Hepat